Lilly, AstraZeneca Urge CMS Experiments In Value-Based Pricing
Executive Summary
Center for Medicare and Medicaid Innovation should find ways to overcome the 'best price' dilemma and other obstacles to outcomes-based contracting, manufacturers say.